PKC alpha (PRKCA) Human shRNA Plasmid Kit (Locus ID 5578)
CAT#: TR320466
PRKCA - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 2 publications. |
Product images
经常一起买 (2)
PRKCA mouse monoclonal antibody, clone OTI5F4
CNY 1,999.00
CNY 3,600.00
Specifications
Product Data | |
Product Name | PKC alpha (PRKCA) Human shRNA Plasmid Kit (Locus ID 5578) |
Locus ID | 5578 |
UniProt ID | P17252 |
Synonyms | AAG6; PKC-alpha; PKCA; PKCalpha; PKCI+/-; PRKACA |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | PRKCA - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 5578). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | BC011942, NM_002737, NM_002737.1, NM_002737.2, BC015855, BC053321, BC062759, BC071767, BC103691, BC107592, BC109273, BC109274, BC122530, BM015483 |
Summary | Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and the second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC family members also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play a distinct role in cells. The protein encoded by this gene is one of the PKC family members. This kinase has been reported to play roles in many different cellular processes, such as cell adhesion, cell transformation, cell cycle checkpoint, and cell volume control. Knockout studies in mice suggest that this kinase may be a fundamental regulator of cardiac contractility and Ca(2+) handling in myocytes. [provided by RefSeq, Jul 2008] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
Caveolin-1 promotes resistance to chemotherapy-induced apoptosis in Ewing's sarcoma cells by modulating PKC{ALPHA} phosphorylation
,Oscar M. Tirado, Caitlin M. MacCarthy, Naheed Fatima, Joaquín Villar, Silvia Mateo-Lozano, Vicente Notario,
[PRKCA]
|
PCPH/ENTPD5 Expression Confers to Prostate Cancer Cells Resistance against Cisplatin-Induced Apoptosis through Protein Kinase C–Mediated Bcl-2 Stabilization
,Joaquín Villar, Humair S. Quadri, Insun Song, York Tomita, Oscar M. Tirado, and Vicente Notario,
Cancer Res., Jan 2009; 69: 102 - 110.
[PRKCA]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...